In a research study on HepG2 cells subjected to high glucose and in high-fat NAFLD models, it was found that the methylation status of the NFE2L2 gene increased, whereas that of Keap1 decreased, resulting in reduced NRF2 expression and activity. Here, NFE2L2 is linked to metabolic dysfunction-associated steatotic liver disease.